RTP-based GeneCentric Therapeautics will inject an additional $2.5 million in the company’s development and commercialization of RNA-based diagnostic tests.
Read More
WRAL TechWire discusses the future of life science, the difference between RNA and DNA, and the current and future funding environment for biotech companies with Dr. Michael Milburn, CEO of GeneCentric.
Read More
The strategic collaboration between a startup – GeneCentric Therapeutics – and international life science giant Labcorp was about a year in the making, GeneCentric Therapeutics president and CEO Michael Milburn tells WRAL TechWire. Here’s the backstory.
Read More
GeneCentric disclosed it had raised $4.5 million. Today, the company announced that Labcorp had made a strategic investment.
Read More
GeneCentric Therapeutics has raised $4.5 million in equity from one investor, and it could raise $3 million more.
Read More
Financial terms weren’t disclosed. It’s a match that will combine informatics with immuno-therapeutics (using the body’s natural immune system to fight cancer).
Read More
